韩旻, 李畅, 郭望葳, 刘惠娜, 梁文权, 高建青. 线粒体靶向药物输送抗肿瘤的研究进展J. 药学学报, 2016,51(2): 257-263. doi: 10.16438/j.0513-4870.2015-0875
引用本文: 韩旻, 李畅, 郭望葳, 刘惠娜, 梁文权, 高建青. 线粒体靶向药物输送抗肿瘤的研究进展J. 药学学报, 2016,51(2): 257-263. doi: 10.16438/j.0513-4870.2015-0875
HAN Min, LI Chang, GUO Wang-wei, LIU Hui-na, LIANG Wen-quan, GAO Jian-qing. Mitochondrial drug delivery for cancer therapyJ. Acta Pharmaceutica Sinica, 2016,51(2): 257-263. doi: 10.16438/j.0513-4870.2015-0875
Citation: HAN Min, LI Chang, GUO Wang-wei, LIU Hui-na, LIANG Wen-quan, GAO Jian-qing. Mitochondrial drug delivery for cancer therapyJ. Acta Pharmaceutica Sinica, 2016,51(2): 257-263. doi: 10.16438/j.0513-4870.2015-0875

线粒体靶向药物输送抗肿瘤的研究进展

Mitochondrial drug delivery for cancer therapy

  • 摘要: 线粒体是人体组织细胞中的重要细胞器,参与多种代谢过程,其功能障碍与癌症、神经退行性疾病、肥胖和缺血再灌注损伤等难治愈疾病密切相关。因此,线粒体靶向药物研究日益受到重视,本文将简要介绍线粒体与人类疾病,尤其是与肿瘤的关系,概述当前线粒体靶向药物传递系统的设计策略和发展趋势。

     

    Abstract: Mitochondrion is one of the most vital organelles in cells of human body, and it is involved in many metabolic processes. Mitochondrion dysfunction is closely related to many diseases such as cancers, neurodegenerative diseases, obesity and ischemia reperfusion injury. As a result, mitochondrial drug delivery has gained more and more attention in the drug discovery against these diseases. This review gives a brief introduction to the relationship between mitochondria and human diseases (e.g., cancer), and summarizes the latest trend of mitochondrial targeting drug delivery system (MTDDS).

     

/

返回文章
返回